Anti-Mullerian hormone as an ovarian reserve marker in women
with the most frequent muscular dystrophies

J 2020

Anti-Mullerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies

PARMOVÁ, Olesja, Eva VLČKOVÁ, Monika HULOVÁ, Livie MENSOVA, Igor CRHA et. al.

Basic information

Original name

Anti-Mullerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies

Authors

PARMOVÁ, Olesja (203 Czech Republic, belonging to the institution), Eva VLČKOVÁ (203 Czech Republic, belonging to the institution), Monika HULOVÁ (203 Czech Republic, belonging to the institution), Livie MENSOVA (203 Czech Republic), Igor CRHA (203 Czech Republic, belonging to the institution), Petra STRÁDALOVÁ (203 Czech Republic, belonging to the institution), Eva KRALICKOVA (203 Czech Republic), Lenka JUŘÍKOVÁ (203 Czech Republic, belonging to the institution), Martina PODBORSKÁ (203 Czech Republic), Radim MAZANEC (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Josef BEDNAŘÍK (203 Czech Republic, belonging to the institution), Stanislav VOHÁŇKA (203 Czech Republic, belonging to the institution) and Iva ŠROTOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Medicine, Philadelphia, Lippincott Williams & Wilkins, 2020, 0025-7974

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30218 General and internal medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 1.889

RIV identification code

RIV/00216224:14110/20:00116134

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1097/MD.0000000000020523

UT WoS

000549892300041

Keywords in English

anti-Mullerian hormone; fertility; muscular dystrophy; myotonic dystrophy; ovarian reserve

Abstract

V originále

Some muscular dystrophies may have a negative impact on fertility. A decreased ovarian reserve is 1 of the factors assumed to be involved in fertility impairment. AMH (anti-Mullerian hormone) is currently considered the best measure of ovarian reserve. A total of 21 females with myotonic dystrophy type 1 (MD1), 25 females with myotonic dystrophy type 2 (MD2), 12 females with facioscapulohumeral muscular dystrophy (FSHD), 12 female carriers of Duchenne muscular dystrophy mutations (cDMD) and 86 age-matched healthy controls of reproductive age (range 18 - 44 years) were included in this case control study. An enzymatically amplified 2-site immunoassay was used to measure serum AMH level. The MD1 group shows a significant decrease of AMH values (median 0.7ng/mL; range 0 - 4.9ng/mL) compared with age-matched healthy controls (P<.01). AMH levels were similar between patients and controls in terms of females with MD2 (P=.98), FSHD (P=.55) and cDMD (P=.60). This study suggests decreased ovarian reserve in women with MD1, but not in MD2, FSHD and cDMD.

Links

MUNI/A/1072/2017, interní kód MU

Name: Diagnostika a patofyziologie neuropatické bolesti (Acronym: PNB)

Investor: Masaryk University, Category A

MUNI/A/1325/2019, interní kód MU

Name: Diagnostika a patofyziologie neuropatické bolesti (Acronym: PNB)

Investor: Masaryk University, Category A

Citovat

PARMOVÁ, Olesja, Eva VLČKOVÁ, Monika HULOVÁ, Livie MENSOVA, Igor CRHA, Petra STRÁDALOVÁ, Eva KRALICKOVA, Lenka JUŘÍKOVÁ, Martina PODBORSKÁ, Radim MAZANEC, Ladislav DUŠEK, Jiří JARKOVSKÝ, Josef BEDNAŘÍK, Stanislav VOHÁŇKA and Iva ŠROTOVÁ. Anti-Mullerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies. Medicine. Philadelphia: Lippincott Williams & Wilkins, 2020, vol. 99, No 23, p. 1-6. ISSN 0025-7974. Available from: https://dx.doi.org/10.1097/MD.0000000000020523.

@article{1673177,
   author = {Parmová, Olesja and Vlčková, Eva and Hulová, Monika and Mensova, Livie and Crha, Igor and Strádalová, Petra and Kralickova, Eva and Juříková, Lenka and Podborská, Martina and Mazanec, Radim and Dušek, Ladislav and Jarkovský, Jiří and Bednařík, Josef and Voháňka, Stanislav and Šrotová, Iva},
   article_location = {Philadelphia},
   article_number = {23},
   doi = {http://dx.doi.org/10.1097/MD.0000000000020523},
   keywords = {anti-Mullerian hormone; fertility; muscular dystrophy; myotonic dystrophy; ovarian reserve},
   language = {eng},
   issn = {0025-7974},
   journal = {Medicine},
   title = {Anti-Mullerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies},
   url = {https://journals.lww.com/md-journal/FullText/2020/06050/Anti_M_llerian_hormone_as_an_ovarian_reserve.42.aspx},
   volume = {99},
   year = {2020}
}

TY  - JOUR
ID  - 1673177
AU  - Parmová, Olesja - Vlčková, Eva - Hulová, Monika - Mensova, Livie - Crha, Igor - Strádalová, Petra - Kralickova, Eva - Juříková, Lenka - Podborská, Martina - Mazanec, Radim - Dušek, Ladislav - Jarkovský, Jiří - Bednařík, Josef - Voháňka, Stanislav - Šrotová, Iva
PY  - 2020
TI  - Anti-Mullerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies
JF  - Medicine
VL  - 99
IS  - 23
SP  - 1-6
EP  - 1-6
PB  - Lippincott Williams & Wilkins
SN  - 00257974
KW  - anti-Mullerian hormone
KW  - fertility
KW  - muscular dystrophy
KW  - myotonic dystrophy
KW  - ovarian reserve
UR  - https://journals.lww.com/md-journal/FullText/2020/06050/Anti_M_llerian_hormone_as_an_ovarian_reserve.42.aspx
L2  - https://journals.lww.com/md-journal/FullText/2020/06050/Anti_M_llerian_hormone_as_an_ovarian_reserve.42.aspx
N2  - Some muscular dystrophies may have a negative impact on fertility. A decreased ovarian reserve is 1 of the factors assumed to be involved in fertility impairment. AMH (anti-Mullerian hormone) is currently considered the best measure of ovarian reserve. A total of 21 females with myotonic dystrophy type 1 (MD1), 25 females with myotonic dystrophy type 2 (MD2), 12 females with facioscapulohumeral muscular dystrophy (FSHD), 12 female carriers of Duchenne muscular dystrophy mutations (cDMD) and 86 age-matched healthy controls of reproductive age (range 18 - 44 years) were included in this case control study. An enzymatically amplified 2-site immunoassay was used to measure serum AMH level. The MD1 group shows a significant decrease of AMH values (median 0.7ng/mL; range 0 - 4.9ng/mL) compared with age-matched healthy controls (P<.01). AMH levels were similar between patients and controls in terms of females with MD2 (P=.98), FSHD (P=.55) and cDMD (P=.60). This study suggests decreased ovarian reserve in women with MD1, but not in MD2, FSHD and cDMD.
ER  -

PARMOVÁ, Olesja, Eva VLČKOVÁ, Monika HULOVÁ, Livie MENSOVA, Igor CRHA, Petra STRÁDALOVÁ, Eva KRALICKOVA, Lenka JUŘÍKOVÁ, Martina PODBORSKÁ, Radim MAZANEC, Ladislav DUŠEK, Jiří JARKOVSKÝ, Josef BEDNAŘÍK, Stanislav VOHÁŇKA and Iva ŠROTOVÁ. Anti-Mullerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies. \textit{Medicine}. Philadelphia: Lippincott Williams \&{} Wilkins, 2020, vol.~99, No~23, p.~1-6. ISSN~0025-7974. Available from: https://dx.doi.org/10.1097/MD.0000000000020523.

Detailed Information on Publication Record